featured
Evaluation of a Delayed Liver Transplantation Strategy for Patients With HCC Receiving Bridging Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study
J. Hepatol. 2024 Aug 01;81(2)278-288, C Lamarque, L Segaux, P Bachellier, B Buchard, F Chermak, F Conti, T Decaens, S Dharancy, V Di Martino, J Dumortier, C Francoz-Caudron, J Gugenheim, J Hardwigsen, F Muscari, S Radenne, E Salamé, T Uguen, J Ursic-Bedoya, C Antoine, A Deshayes, C Jacquelinet, PA Natella, V Leroy, D Cherqui, N Oubaya, C DuvouxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.